Bi-HPDO3A as a novel contrast agent for X-ray computed tomography.

ABSTRACT: A new bismuth-based CT agent was synthesized through a facile synthesis strategy. The in vitro stability, toxicity and CT performance were evaluated. The in vivo imaging performance was investigated using three different doses (0.5, 1.2 and 5 mmol/kg) and the result obtained at 1.2 mmol/kg was compared with the clinically approved CT agent iopamidol at the same dosage.

SUBMITTER: Rizzo R 

PROVIDER: S-EPMC10556142 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature